CONTROL Resonant Launch Lifts Remedy to Quarterly Operating Profit

Remedy Entertainment reported on November 3, 2026, that third-quarter revenue rose 226.0% to €39.6 million from €12.2 million a year earlier, following the launch of CONTROL Resonant. It also posted €0.6 million in operating profit, reversing a €16.4 million loss in the comparison quarter.

The digital version of CONTROL Resonant launched worldwide across all platforms on September 24, 2026, meaning the quarter included preorders and only its first seven days of sales. Chief executive Jean-Charles Gaudechon described it as Remedy’s first self-published game of this scale, built on the company’s own CONTROL IP, and called it “a defining milestone for the company.”

On October 15, 2026, Remedy said worldwide sales had passed one million copies three weeks after launch, coinciding with the physical edition’s release and making CONTROL Resonant the fastest-selling game in the company’s history.

Self-Publishing Reshapes the Quarter

Game sales and royalties supplied €35.3 million, or 89% of quarterly revenue, up from €6.0 million. Development fees fell to €4.3 million from €6.1 million; they came from Max Payne 1&2 remake and the final development-fee accrual for CONTROL Resonant under Remedy’s agreement with Annapurna Pictures.

The self-publishing model also brought the associated costs directly onto Remedy’s income statement. Materials and services expenses rose by €17.0 million to €20.0 million, mainly because higher game sales increased royalty expenses and platform fees; those royalties include Annapurna’s share of CONTROL Resonant revenue. Other operating expenses climbed by €5.4 million to €8.0 million as launch marketing accelerated, and Gaudechon described the campaign as Remedy’s largest marketing investment to date.

Even with those launch costs, EBITDA, which Remedy defines as operating profit plus depreciation, amortization and impairment, reached €6.8 million, compared with €0.7 million a year earlier.

The year-earlier operating loss also included a €14.9 million non-cash impairment related to FBC: Firebreak, so that charge accounts for much of the difference between the two quarters. Excluding the impairment, depreciation increased by €4.0 million, mainly because Remedy began depreciating CONTROL Resonant’s capitalized development costs at launch.

Launch Audience and Cash Timing

Remedy said its analytic data showed close to 50% of CONTROL Resonant players were new to CONTROL, while outstanding wishlists stood at 2.4 million. The wishlist count represents a potential audience rather than completed sales.

The original Control also exceeded its year-earlier third-quarter sales and its sales in each of the first two quarters of 2026. Remedy connected that lift to franchise interest and promotions surrounding the sequel’s launch.

For the first nine months, revenue increased 48.2% to €62.9 million from €42.5 million, while the operating loss narrowed to €2.3 million from €15.6 million. Those figures put the launch quarter in context: revenue was higher across the year, but the business remained loss-making at operating level for the period.

Third-quarter operating cash flow was negative €0.1 million because of incoming-payment timing, with receivables rising as some game-sale payments were expected in future periods. Cash and liquid investments totaled €24.1 million on September 30, 2026, compared with €36.5 million a year earlier.

Remedy kept its 2026 outlook unchanged, expecting full-year revenue and EBITDA to increase from the previous year. CONTROL Resonant is now in post-launch development, an unnamed self-published project is at production readiness, and the Rockstar Games-published Max Payne 1&2 remake is in full production.

Gaudechon said sales over the remainder of the year will ultimately define financial year 2026. The central question is whether the expanded CONTROL audience can sustain momentum after launch, because the quarter’s higher revenue arrived alongside direct partner and platform costs, heavier marketing spending and delayed cash receipts.